ReviewFrontiers in nutrition2025
Advances and challenges in nutritional screening and assessment for cancer patients: a comprehensive systematic review and future directions.
Review in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Dietary Habits, Nutritional Knowledge, and Quality of Life Among Patients with Gastrointestinal Cancers: An Exploratory Cross-Sectional Survey.Journal of clinical medicine · 2026Article
- Article
- Nutritional Status and Associated Factors Among Adult Gastrointestinal Cancer Patients at a Tertiary Hospital of Ethiopia: A Cross-Sectional Study.Cancer reports (Hoboken, N.J.) · 2026Article
- Pathogenesis, Diagnostic Pathways, and New Therapeutic and Nutritional Strategies for Pancreatic Cancer-Associated Cachexia.Cancers · 2026Review
- Effect of Prehabilitation-Based Individualized Dietary Guidance on Nutrition and Short-Term Quality of Life in Locally Advanced Gastric Cancer Patients Undergoing Surgery: A Single-Center Randomized Controlled Trial.Journal of multidisciplinary healthcare · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cancer-associated malnutrition is a pervasive and under-recognized complication that profoundly impacts treatment tolerance, clinical outcomes, and quality of life. Despite the availability of multiple nutritional screening and assessment tools, these instruments differ widely in sensitivity, specificity, and ease of integration into clinical workflows, and no universally accepted standard exists. This review critically examines the current landscape of malnutrition assessment in oncology, summarizes tool performance across populations and cancer types, and proposes strategies-such as artificial intelligence-enabled models and internationally harmonized protocols-to improve diagnosis, treatment planning, and overall patient outcomes. Methods: A comprehensive literature search was conducted across PubMed, Web of Science, Embase, and Elsevier databases, covering studies published up to 13 March 2025. Medical Subject Headings (MeSH) were used to identify terms including "malnutrition," "cachexia," "cancer," "nutritional status assessment," "nutritional screening," and "nutritional screening tool." Boolean operators refined the strategy, and a two-stage screening excluded studies with irrelevant populations, outcomes, or designs, as well as non-peer-reviewed sources. Results: Significant heterogeneity was found in tool performance and applicability across cancer types, clinical settings, and demographic subgroups. General instruments such as the Malnutrition Universal Screening Tool (MUST) and Nutritional Risk Screening 2002 (NRS-2002) demonstrated strong predictive validity in broad clinical use, whereas condition-specific tools like Patient-Generated Subjective Global Assessment (PG-SGA) offered superior sensitivity in high-risk populations, including patients with gastric or head and neck cancers. However, variability in thresholds, assessment frequency, and validation approaches highlights the urgent need for standardization. Discussion: Current assessment strategies are limited by subjectivity, static single-point evaluations, and inconsistent implementation. Future innovations should integrate artificial intelligence, dynamic longitudinal monitoring, and multimodal data analytics to develop objective and personalized evaluation systems. Establishing globally harmonized standards will be crucial to improving nutritional care, reducing malnutrition-related morbidity, and enhancing survival and quality of life for patients with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.